Cited by

• Tricuspid regurgitant jet velocity and hospitalization in Tanzanian children with sickle cell anemia.

  Cox SE, Soka D, Kirkham FJ, Newton CR, Prentice AM, Makani J, Younoszai AK. Cox SE, et al. Haematologica. 2014 Jan;99(1):e1-4. doi: 10.3324/haematol.2013.089235. Haematologica. 2014. PMID: 24425690 Free PMC article. No abstract available.
• Abnormalities in aortic properties: a potential link between left ventricular diastolic function and ventricular-aortic coupling in sickle cell disease.

  Bollache E, Kachenoura N, Lang RM, Desai AA, Mor-Avi V, Patel AR. Bollache E, et al. Int J Cardiovasc Imaging. 2016 Jun;32(6):965-73. doi: 10.1007/s10554-016-0863-7. Epub 2016 Feb 23. Int J Cardiovasc Imaging. 2016. PMID: 26907920
• Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.

  Hsu LL, Champion HC, Campbell-Lee SA, Bivalacqua TJ, Manci EA, Diwan BA, Schimel DM, Cochard AE, Wang X, Schechter AN, Noguchi CT, Gladwin MT. Hsu LL, et al. Blood. 2007 Apr 1;109(7):3088-98. doi: 10.1182/blood-2006-08-039438. Blood. 2007. PMID: 17158223 Free PMC article.
• Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

  Ballas SK, Kesen MR, Goldberg MF, Lutty GA, Dampier C, Osunkwo I, Wang WC, Hoppe C, Hagar W, Darbari DS, Malik P. Ballas SK, et al. ScientificWorldJournal. 2012;2012:949535. doi: 10.1100/2012/949535. Epub 2012 Aug 1. ScientificWorldJournal. 2012. PMID: 22924029 Free PMC article. Review.
• Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease.

  Ashley-Koch AE, Elliott L, Kail ME, De Castro LM, Jonassaint J, Jackson TL, Price J, Ataga KI, Levesque MC, Weinberg JB, Orringer EP, Collins A, Vance JM, Telen MJ. Ashley-Koch AE, et al. Blood. 2008 Jun 15;111(12):5721-6. doi: 10.1182/blood-2007-02-074849. Epub 2008 Jan 10. Blood. 2008. PMID: 18187665 Free PMC article.